Literature DB >> 24461230

Orthopedics coding and funding.

S Baron1, C Duclos2, P Thoreux3.   

Abstract

The French tarification à l'activité (T2A) prospective payment system is a financial system in which a health-care institution's resources are based on performed activity. Activity is described via the PMSI medical information system (programme de médicalisation du système d'information). The PMSI classifies hospital cases by clinical and economic categories known as diagnosis-related groups (DRG), each with an associated price tag. Coding a hospital case involves giving as realistic a description as possible so as to categorize it in the right DRG and thus ensure appropriate payment. For this, it is essential to understand what determines the pricing of inpatient stay: namely, the code for the surgical procedure, the patient's principal diagnosis (reason for admission), codes for comorbidities (everything that adds to management burden), and the management of the length of inpatient stay. The PMSI is used to analyze the institution's activity and dynamism: change on previous year, relation to target, and comparison with competing institutions based on indicators such as the mean length of stay performance indicator (MLS PI). The T2A system improves overall care efficiency. Quality of care, however, is not presently taken account of in the payment made to the institution, as there are no indicators for this; work needs to be done on this topic.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Clinical coding; Diagnosis-related groups; Orthopedics funding; PMSI medical information system; T2A prospective payment system

Mesh:

Year:  2014        PMID: 24461230     DOI: 10.1016/j.otsr.2013.06.009

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  1 in total

1.  The Use of Diagnosis-Related Group-Based Reimbursement in the Czech Hospital Care System.

Authors:  Zuzana Kotherová; Martina Caithamlová; Juraj Nemec; Kateřina Dolejšová
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.